Accuracy of the refractive prediction determined by intraocular lens power calculation formulas in high myopia
It was interesting to read the article "Accuracy of the refractive prediction determined by intraocular lens power calculation formulas in high myopia" by Zhou et al. [1] The authors have compared the predictive accuracy of five formulas and concluded that Barrett Universal II is the more reliable formula.
However, we wish to point out certain concerns which we thought were important:-1. The type of intraocular lens used in the study is not mentioned specifically. Different IOL designs might affect the outcome precision [2, 3] 2. Mean absolute error (MAE) among the formulas is compared. It is important to note that absolute errors are not a normal Gaussian distribution. Therefore, it is best to compare median absolute error (MedAE) rather than MAE. [4] In results MedAE is mentioned as a heading but under that MAE and interquartile range are described 3. The differences in mean numerical error and MAE of five formulas were compared but the results were not statistically proven (no P values mentioned) 4. In Fig. 1 and 2 of main article, X-axis should be mentioned as within ± 0.25 D, ± 0.50 D, ± 1.00 D and ± 2.00 D as depicted in Fig. 1 .
Figure 1:
Percentage of eyes with refractive prediction errors within ± 0.25 D, ± 0.50 D, ± 1.00 D and ± 2.00 D 5. Fig. 3 of the article, depicts as if all patients in groups 1, 2, and 3 have exactly the same axial length, this may not be in reality. Also, it is not fare enough to depict correlation of all three groups in the same figure 6. Which Holladay formula was used? -Holladay 1 or 2 7. There is confusion regarding type of biometer used in the study. In methodology Lenstar and contact-type A ultrasound are mentioned while in results IOL master. These three instruments use different technology for biometry. Contact ultrasound biometry is not optimal because of potential corneal compression and shorter axial length and anterior chamber depth measurement. [5] Indian Journal of Ophthalmology 
Comments on: Biometric changes in Indian pediatric cataract and postoperative refractive status
We read with interest the article "Biometric changes in Indian pediatric cataract and postoperative refractive status" by Khokhar et al. [1] The authors have commendably evaluated the biometric changes in Indian pediatric cataract and this contributes well to the present literature.
We seek information on the following points which would give further clarity to the readers: 1. Was there any relationship between the laterality of cataract and axial length growth? In some publications of ocular growth and pediatric cataract, laterality is a useful variable in predicting axial length growth. [2, 3] As the authors have data of both unilateral and bilateral cataracts, this would be a useful addition to literature. Moreover, lesser undercorrection is done in unilateral cataracts as there are increased chances of dense amblyopia not only due to laterality but also due to anisometropia and unilateral loss of accommodation following surgery [4] 2. The authors have mentioned first postoperative refraction on day 1 post surgery. Does that mean that on 1 st day repeat general anaesthesia (GA) was given? Also the reliability of refraction is expected to be suboptimal taking into account the 1 st day effects on (a) cornea-recent incision, suture, and hydration; (b) anterior chamber-presence of air, residual visco elastic, or balanced salt solution; and (c) intraocular pressure 3. While the percentage reduction achieved in different groups is clear, which nomogram has been used preoperatively to achieve the same is unclear. Moreover, is it appropriate to use Sanders, Retzlaff, Kraff (SRK) II formula for all axial lengths >17 mm? [5] Although 6 months follow-up has been mentioned as a limitation, nevertheless this study does cover the crucial period during which the eye is undergoing most rapid phase of axial growth in infants. It would be useful to continue the follow-up of these children to reach more meaningful conclusions.
Financial support and sponsorship
Nil.
